Suppr超能文献

肩胛腓骨肌萎缩症和 CMT2C 是由 TRPV4 改变引起的等位基因疾病。

Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4.

机构信息

Davee Department of Neurology and Clinical Neurosciences, Northwestern University Feinberg School of Medicine, Chicago, Illinois, USA.

出版信息

Nat Genet. 2010 Feb;42(2):165-9. doi: 10.1038/ng.509. Epub 2009 Dec 27.

Abstract

Scapuloperoneal spinal muscular atrophy (SPSMA) and hereditary motor and sensory neuropathy type IIC (HMSN IIC, also known as HMSN2C or Charcot-Marie-Tooth disease type 2C (CMT2C)) are phenotypically heterogeneous disorders involving topographically distinct nerves and muscles. We originally described a large New England family of French-Canadian origin with SPSMA and an American family of English and Scottish descent with CMT2C. We mapped SPSMA and CMT2C risk loci to 12q24.1-q24.31 with an overlapping region between the two diseases. Further analysis reduced the CMT2C risk locus to a 4-Mb region. Here we report that SPSMA and CMT2C are allelic disorders caused by mutations in the gene encoding the transient receptor potential cation channel, subfamily V, member 4 (TRPV4). Functional analysis revealed that increased calcium channel activity is a distinct property of both SPSMA- and CMT2C-causing mutant proteins. Our findings link mutations in TRPV4 to altered calcium homeostasis and peripheral neuropathies, implying a pathogenic mechanism and possible options for therapy for these disorders.

摘要

肩腓型脊柱肌萎缩症(SPSMA)和遗传性运动感觉神经病 IIC 型(HMSN IIC,也称为 HMSN2C 或 Charcot-Marie-Tooth 病 2C 型(CMT2C))是表型异质性疾病,涉及到不同部位的神经和肌肉。我们最初描述了一个大型新英格兰法裔加拿大家族患有 SPSMA,以及一个具有英裔和苏格兰血统的美国家族患有 CMT2C。我们将 SPSMA 和 CMT2C 的风险基因座映射到 12q24.1-q24.31,两个疾病之间有重叠区域。进一步的分析将 CMT2C 的风险基因座缩小到 4-Mb 区域。在这里,我们报告 SPSMA 和 CMT2C 是由编码瞬时受体电位阳离子通道亚家族 V,成员 4(TRPV4)的基因突变引起的等位基因疾病。功能分析表明,钙通道活性的增加是 SPSMA 和 CMT2C 致病突变蛋白的一个独特特征。我们的发现将 TRPV4 的突变与钙稳态的改变和周围神经病变联系起来,暗示了这些疾病的发病机制和可能的治疗选择。

相似文献

1
Scapuloperoneal spinal muscular atrophy and CMT2C are allelic disorders caused by alterations in TRPV4.
Nat Genet. 2010 Feb;42(2):165-9. doi: 10.1038/ng.509. Epub 2009 Dec 27.
3
Mutations in TRPV4 cause Charcot-Marie-Tooth disease type 2C.
Nat Genet. 2010 Feb;42(2):170-4. doi: 10.1038/ng.512. Epub 2009 Dec 27.
4
Alterations in the ankyrin domain of TRPV4 cause congenital distal SMA, scapuloperoneal SMA and HMSN2C.
Nat Genet. 2010 Feb;42(2):160-4. doi: 10.1038/ng.508. Epub 2009 Dec 27.
5
Incidence and Clinical Features of TRPV4-Linked Axonal Neuropathies in a USA Cohort of Charcot-Marie-Tooth Disease Type 2.
Neuromolecular Med. 2020 Mar;22(1):68-72. doi: 10.1007/s12017-019-08564-4. Epub 2019 Aug 29.
6
Channelopathies converge on TRPV4.
Nat Genet. 2010 Feb;42(2):98-100. doi: 10.1038/ng0210-98.
7
Phenotypic variability of TRPV4 related neuropathies.
Neuromuscul Disord. 2015 Jun;25(6):516-21. doi: 10.1016/j.nmd.2015.03.007. Epub 2015 Mar 18.
8
TRPV4 related scapuloperoneal spinal muscular atrophy: Report of an Italian family and review of the literature.
Neuromuscul Disord. 2016 Apr-May;26(4-5):312-5. doi: 10.1016/j.nmd.2016.02.010. Epub 2016 Feb 23.
9
TRPV4 mutations and cytotoxic hypercalcemia in axonal Charcot-Marie-Tooth neuropathies.
Neurology. 2011 Mar 8;76(10):887-94. doi: 10.1212/WNL.0b013e31820f2de3. Epub 2011 Feb 2.
10
CMT2C with vocal cord paresis associated with short stature and mutations in the TRPV4 gene.
Neurology. 2010 Nov 30;75(22):1968-75. doi: 10.1212/WNL.0b013e3181ffe4bb.

引用本文的文献

3
TRPV4 Channel in Neurological Disease: from Molecular Mechanisms to Therapeutic Potential.
Mol Neurobiol. 2025 Mar;62(3):3877-3891. doi: 10.1007/s12035-024-04518-5. Epub 2024 Sep 28.
9
Case Report: gene mutation causing neuronopathy, distal hereditary motor, type VIII.
Front Pediatr. 2024 Mar 18;12:1327742. doi: 10.3389/fped.2024.1327742. eCollection 2024.
10
The implementation and utility of clinical exome sequencing in a South African infant cohort.
Front Genet. 2023 Nov 9;14:1277948. doi: 10.3389/fgene.2023.1277948. eCollection 2023.

本文引用的文献

2
Molecular mechanisms of TRPV4-mediated neural signaling.
Ann N Y Acad Sci. 2008 Nov;1144:42-52. doi: 10.1196/annals.1418.012.
3
Gain-of-function mutations in TRPV4 cause autosomal dominant brachyolmia.
Nat Genet. 2008 Aug;40(8):999-1003. doi: 10.1038/ng.166. Epub 2008 Jun 29.
4
Structural analyses of the ankyrin repeat domain of TRPV6 and related TRPV ion channels.
Biochemistry. 2008 Feb 26;47(8):2476-84. doi: 10.1021/bi702109w. Epub 2008 Jan 31.
7
Stimulus-specific modulation of the cation channel TRPV4 by PACSIN 3.
J Biol Chem. 2008 Mar 7;283(10):6272-80. doi: 10.1074/jbc.M706386200. Epub 2008 Jan 3.
8
OS-9 regulates the transit and polyubiquitination of TRPV4 in the endoplasmic reticulum.
J Biol Chem. 2007 Dec 14;282(50):36561-70. doi: 10.1074/jbc.M703903200. Epub 2007 Oct 11.
9
Transient receptor potential cation channels in disease.
Physiol Rev. 2007 Jan;87(1):165-217. doi: 10.1152/physrev.00021.2006.
10
The HECT ubiquitin ligase AIP4 regulates the cell surface expression of select TRP channels.
EMBO J. 2006 Dec 13;25(24):5659-69. doi: 10.1038/sj.emboj.7601429. Epub 2006 Nov 16.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验